Anika Therapeutics, Inc.
A maker of joint-preservation and tissue-repair products built on hyaluronic acid — the same slippery substance that naturally cushions human joints. Its injectable treatments Orthovisc, Monovisc, and CINGAL ease osteoarthritis knee pain, while its surgical implants help regenerate torn tendons. Formed in 1992 as a spin-off of MedChem Products, this Bedford, Massachusetts company's products were long sold in the US under the Johnson & Johnson brand rather than its own name.
Sold 1.27M
Granted 381.2K · Bought 8.1K
Granted 1.05M · Sold 634.4K
Granted 42.7K · Sold 23.3K
Granted 84.9K · Bought 3.0K
Granted 58.3K · Bought 7.0K
Granted 58.3K
Granted 53.0K
Granted 49.7K
Granted 54.6K · Sold 4.4K
Granted 50.2K
Granted 44.9K · Bought 12.2K
Granted 73.7K · Sold 24.0K
Granted 48.5K · Bought 7.6K
Granted 93.1K · Bought 9.0K · Sold 75.0K
Granted 87.5K · Sold 540
Granted 83.2K · Sold 53.5K
Granted 55.5K · Bought 2.0K · Sold 25.9K
Granted 30.8K
Granted 34.1K
Granted 9.8K
Granted 20.4K
Granted 20.3K
Granted 28.9K · Sold 5.3K
Granted 22.0K · Bought 1.0K
Granted 4.1K · Sold 2.0K
Granted 28.8K · Sold 14.0K
Granted 54.7K · Sold 40.4K
Granted 13.8K · Sold 13.3K
Granted 10.0K
Granted 4.3K · Bought 1.5K
Granted 7.9K · Sold 640
Granted 6.1K
Granted 109.5K · Sold 68.5K
Granted 7.6K · Sold 1.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Fidia Farmaceutici S.p.A. +2 co-filers10% owner · 1 transaction | — | 1.42Mas of Aug 2013 | — | — | 1.27M |
| Blanchard Cheryl RDirector · 35 transactions | — | 282.6K | 381.2K | 8.1K | — |
| Sherwood Charles HCEO and Director, Director · 207 transactions | — | 189.9Kas of Jan 2018 | 1.05M | — | 634.4K |
| Davidson Eugene ADirector · 42 transactions | — | 71.8Kas of Jan 2011 | 42.7K | — | 23.3K |
| Colleran DavidEVP, General Counsel, Corp Sec · 32 transactions | — | 67.6K | 84.9K | 3.0K | — |
| Henneman John B IIIDirector · 9 transactions | — | 65.3K | 58.3K | 7.0K | — |
| Richard StephenDirector · 7 transactions | — | 58.3K | 58.3K | — | — |
| Conley Sheryl LDirector · 6 transactions | — | 53.0K | 53.0K | — | — |
| Fischetti Gary PDirector · 5 transactions | — | 52.0K | 49.7K | — | — |
| Larsen Glenn R.Director · 12 transactions | — | 50.3Kas of Jun 2025 | 54.6K | — | 4.4K |
| Vogt Susan L NDirector · 8 transactions | — | 50.2Kas of Jun 2025 | 50.2K | — | — |
| Griffin Stephen D.President and CEO, Director · 8 transactions | — | 49.7K | 44.9K | 12.2K | — |
| Cheung SylviaChief Financial Officer · 18 transactions | — | 49.3Kas of Feb 2020 | 73.7K | — | 24.0K |
| Levitz Michael LEVP, CFO, Treasurer · 18 transactions | — | 47.0Kas of Mar 2024 | 48.5K | 7.6K | — |
| Quinlan Kevin WChief Financial Officer · 20 transactions | — | 45.5Kas of Mar 2013 | 93.1K | 9.0K | 75.0K |
| Bower Joseph IDirector · 26 transactions | — | 45.0Kas of Feb 2019 | 87.5K | — | 540 |
| Wheeler Steve EDirector · 30 transactions | — | 34.6Kas of Jan 2018 | 83.2K | — | 53.5K |
| Thompson Jeffery SDirector · 22 transactions | — | 31.6Kas of Jun 2023 | 55.5K | 2.0K | 25.9K |
| Capper Joseph HDirector · 4 transactions | — | 30.8K | 30.8K | — | — |
| Finnerty ThomasEVP, Human Resources · 17 transactions | — | 25.3Kas of Mar 2022 | 34.1K | — | — |
| McLeod IanSVP, CAO & Treasurer · 7 transactions | — | 24.9K | 9.8K | — | — |
| Jellison William RDirector · 3 transactions | — | 23.1Kas of Jun 2025 | 20.4K | — | — |
| Nunes AnneSVP, Chief Operations Officer · 14 transactions | — | 21.7Kas of Mar 2025 | 20.3K | — | — |
| Hague RichardChief Commercial Officer · 5 transactions | — | 21.4Kas of Feb 2019 | 28.9K | — | 5.3K |
| Darling Joseph GPresident and CEO, Director, Director · 5 transactions | — | 20.3Kas of Jul 2019 | 22.0K | 1.0K | — |
| Bower Joseph L.Director · 3 transactions | — | 17.1Kas of Feb 2020 | 4.1K | — | 2.0K |
| Moran John CDirector · 13 transactions | — | 14.8Kas of Aug 2015 | 28.8K | — | 14.0K |
| Land Raymond JDirector · 35 transactions | — | 12.1Kas of Jun 2021 | 54.7K | — | 40.4K |
| Sadow Harvey SDirector · 3 transactions | — | 10.0Kas of Sep 2006 | 13.8K | — | 13.3K |
| Sheets John W JrChief Scientific Officer · 1 transaction | — | 10.0Kas of Oct 2013 | 10.0K | — | — |
| Mrachek WilliamVice President, Human Resource · 3 transactions | — | 6.9Kas of Aug 2010 | 4.3K | 1.5K | — |
| Ahn Edward S.Chief Tech & Strategy Officer · 3 transactions | — | 6.6Kas of Feb 2019 | 7.9K | — | 640 |
| Barnett Carol AChief Commercial Officer · 1 transaction | — | 6.1Kas of Jan 2014 | 6.1K | — | — |
| Luppino Francesco JChief Operating Officer · 38 transactions | — | 6.0Kas of Mar 2012 | 109.5K | — | 68.5K |
| Loerop JamesEVP Business Development · 5 transactions | — | 5.6Kas of Jul 2021 | 7.6K | — | 1.2K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -2.20M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.